Pratt, Arthur G <br/><br/>
Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Oct 2016 
 - 1843-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kew261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Autoantibodies--blood<br/>Family Practice--statistics & numerical data<br/>Female<br/>Hospitalization--statistics & numerical data<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Medical Audit<br/>Middle Aged<br/>Time-to-Treatment